Learn how to customize your 'Roblox' avatar with pro-level tips, creative ideas, and advanced tricks to help you stand out ...
Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback